对《高程序性死亡受体配体1表达表明HIV感染的非小细胞肺癌患者预后不良》的更正
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer.
作者信息
Okuma Yusuke, Hishima Tsunekazu, Kashima Jumpei, Homma Sadamu
机构信息
Divison of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Manato, Tokyo, 105-8461, Japan.
Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.
出版信息
Cancer Immunol Immunother. 2018 Sep;67(9):1477-1479. doi: 10.1007/s00262-018-2215-z.
Abstract
The graphs are incorrectly identified in Fig. 3i, s and should be replaced with the following.
摘要
图3i、s中的图表标识错误，应替换为以下内容。
相似文献
1
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer.
Cancer Immunol Immunother. 2018 Sep;67(9):1477-1479. doi: 10.1007/s00262-018-2215-z.
2
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer.
Cancer Immunol Immunother. 2018 Mar;67(3):495-505. doi: 10.1007/s00262-017-2103-y. Epub 2017 Dec 14.
3
Clinical significance of PDL1 expression in patients with surgically resected nonsmall cell lung cancer.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Oct 28;45(10):1149-1154. doi: 10.11817/j.issn.1672-7347.2020.190101.
4
[PD-L1 expression is related with prognosis of small cell lung cancer].
Zhonghua Zhong Liu Za Zhi. 2019 Mar 23;41(3):214-217. doi: 10.3760/cma.j.issn.0253-3766.2019.03.011.
5
PD-L1 over-expression is associated with a poor prognosis in Asian non-small cell lung cancer patients.
Clin Chim Acta. 2017 Jun;469:191-194. doi: 10.1016/j.cca.2017.02.005. Epub 2017 Feb 7.
6
Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates.
AIDS. 2018 Feb 20;32(4):461-468. doi: 10.1097/QAD.0000000000001713.
7
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
Cancer Immunol Immunother. 2017 Jul;66(7):865-876. doi: 10.1007/s00262-017-1986-y. Epub 2017 Mar 25.
8
Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Pathology. 2021 Feb;53(2):239-246. doi: 10.1016/j.pathol.2020.07.009. Epub 2020 Oct 6.
9
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.
Lung Cancer. 2018 Sep;123:87-90. doi: 10.1016/j.lungcan.2018.06.028. Epub 2018 Jun 26.
10
[CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):254-264. doi: 10.3779/j.issn.1009-3419.2021.103.05.
引用本文的文献
1
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer.
Cancer Manag Res. 2019 Jul 4;11:6125-6138. doi: 10.2147/CMAR.S199832. eCollection 2019.
Zotero 插件